The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Responsiveness assessment of a 3D tetra-culture alveolar model exposed to diesel exhaust particulate matter
Year: 
2018
Journal: 
TOXICOLOGY IN VITRO
Fizesan, I; Chary, A; Cambier, S; Moschini, E; Serchi, T; Nelissen, I; Kiss, B; Pop, A; Loghin, F; Gutleb, AC
Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium
Year: 
2018
Journal: 
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Felix, JF; Joubert, BR; Baccarelli, AA; Sharp, GC; Almqvist, C; Annesi-Maesano, I; Arshad, H; Baiz, N; Bakermans-Kranenburg, MJ; Bakulski, KM; Binder, EB; Bouchard, L; Breton, CV; Brunekreef, B; Brunst, KJ; Burchard, EG; Bustamante, M; Chatzi, L; Munthe-K

Pages